View More Recent Stories

Jul 3, 2024 05:21AM AbbVie (ABBV) option IV flat into 2024 USA elections
Jul 2, 2024 07:23AM Piper Sandler Reiterates Overweight Rating on Abbvie (ABBV)
Jul 1, 2024 08:00AM AbbVie (ABBV) Appoints Robert A. Michael as CEO
Jun 27, 2024 09:27AM AbbVie (ABBV) Acquires Celsius Therapeutics for $250 Million
Jun 27, 2024 08:33AM AbbVie (ABBV) Introduces Alle Payment Plans
Jun 27, 2024 05:44AM AbbVie (ABBV) Announces Second FDA Approval for EPKINLY
Jun 25, 2024 08:15AM AbbVie (ABBV) Issues US Regulatory Update on ABBV-951
Jun 21, 2024 08:01AM AbbVie (ABBV) Declares $1.55 Quarterly Dividend; 3.6% Yield
Jun 20, 2024 08:14AM AbbVie (ABBV) Appoints Roxanne S. Austin to its Board
Jun 18, 2024 07:51AM Abbvie (ABBV) PT Raised to $190 at Piper Sandler
Jun 13, 2024 07:59AM AbbVie (ABBV) and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease
Mar 17, 2024 08:00PM Top pharma stocks to own in 2024 – Citi
Feb 5, 2024 10:30AM This pharma giant is 'firing on all cylinders' - Piper Sandler
View More Recent Stories